Comments
Loading...
Relay Therapeutics (RLAY) Forecast
NewsEarningsRelay Therapeutics (RLAY) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestRelay Therapeutics (NASDAQ:RLAY) Stock Quotes, Forecast and News Summary
Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Relay Therapeutics (RLAY) stock?
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Who are Relay Therapeutics (RLAY) competitors?
Other companies in Relay Therapeutics’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN) and Cogent Biosciences (NASDAQ:COGT).
What is the forecast, or price target, for Relay Therapeutics (RLAY) stock?
Relay Therapeutics has a consensus price target of $21.00.
What is the current price for Relay Therapeutics (RLAY)?
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $3.83 last updated February 26, 2025 at 12:05 PM EST.
Does Relay Therapeutics (RLAY) pay a dividend?
There are no upcoming dividends for Relay Therapeutics.
When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?
Relay Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.
Is Relay Therapeutics (RLAY) going to split?
There is no upcoming split for Relay Therapeutics.
What sector and industry does Relay Therapeutics (RLAY) operate in?
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.